Ultragenyx's gene therapy helps control ammonia levels in late-stage study

March 12 (Reuters) - Ultragenyx Pharmaceutical said on Thursday its experimental gene therapy helped patients in a late-stage trial to better control ammonia levels linked to a rare inherited disorder ...
MPR

Gene Therapy DTX301 Reduces Ammonia in Patients With OTC Deficiency

Enh3ance trial results indicate DTX301 reduces ammonia levels by 18% and supports dietary liberalization in patients with OTC deficiency.

Low intake of protein diet could help slow liver cancer, finds study

A new study shows that lowering protein intake could slow liver cancer in people with damaged livers. Researchers found that ...